These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15310169)

  • 1. The effect of heterogeneity in measles vaccination on population immunity.
    Glass K; Kappey K; Grenfell BT
    Epidemiol Infect; 2004 Aug; 132(4):675-83. PubMed ID: 15310169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination coverage against measles in German-born and foreign-born children and identification of unvaccinated subgroups in Germany.
    Poethko-Müller C; Ellert U; Kuhnert R; Neuhauser H; Schlaud M; Schenk L
    Vaccine; 2009 Apr; 27(19):2563-9. PubMed ID: 19428862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles epidemic in the Netherlands, 1999-2000.
    van den Hof S; Conyn-van Spaendonck MA; van Steenbergen JE
    J Infect Dis; 2002 Nov; 186(10):1483-6. PubMed ID: 12404165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.
    Waibale P; Bowlin SJ; Mortimer EA; Whalen C
    Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The measles are here again].
    Opstelten W; Ruijs WL; Warris A; van Binnendijk RS; Wolfs TF; Hahné SJ
    Ned Tijdschr Geneeskd; 2013; 157(34):A6710. PubMed ID: 23965248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine.
    abu Eldan J; Borćić B; Smerdel S
    Acta Med Croatica; 1991; 45(4-5):297-304. PubMed ID: 1726513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles and measles vaccine isolated amerindian tribes. I. The 1971 Trio ((Tiriyo) epidemic.
    van Mazijk J; Pinheiro FP; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):3-6. PubMed ID: 7080183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis.
    Trentini F; Poletti P; Merler S; Melegaro A
    Lancet Infect Dis; 2017 Oct; 17(10):1089-1097. PubMed ID: 28807627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China.
    Hu Y; Chen Y; Wang Y; Liang H
    Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vaccination coverage, individual behaviors, and the public health response in the control of measles epidemics: an agent-based simulation for California.
    Liu F; Enanoria WT; Zipprich J; Blumberg S; Harriman K; Ackley SF; Wheaton WD; Allpress JL; Porco TC
    BMC Public Health; 2015 May; 15():447. PubMed ID: 25928152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles still spreads in Europe: who is responsible for the failure to vaccinate?
    Carrillo-Santisteve P; Lopalco PL
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():50-6. PubMed ID: 23051058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the Population Susceptibility Against Measles in Slovakia.
    Zibolenová J; Chladná Z; Švihrová V; Baška T; Waczulíková I; Hudečková H
    Cent Eur J Public Health; 2017 Mar; 25(1):46-54. PubMed ID: 28399355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination.
    Enquselassie F; Ayele W; Dejene A; Messele T; Abebe A; Cutts FT; Nokes DJ
    Epidemiol Infect; 2003 Jun; 130(3):507-19. PubMed ID: 12825737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles immunity and response to revaccination among secondary school children in Cumbria.
    Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
    Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial commentary: A rare event: a measles outbreak in a population with high 2-dose measles vaccine coverage.
    Seward JF; Orenstein WA
    Clin Infect Dis; 2012 Aug; 55(3):403-5. PubMed ID: 22543021
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune responses to measles and measles vaccine: challenges for measles control.
    Moss WJ; Polack FP
    Viral Immunol; 2001; 14(4):297-309. PubMed ID: 11792060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.